HCA
LEGN icon

Harbor Capital Advisors’s Legend Biotech LEGN Stock Holding History

Harbor Capital Advisors’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,141
Closed -$655K – 1384
2025
Q4 		$655K Buy
30,141
+5,996
+25% +$172K 0.05% 408
2025
Q3 		$787K Sell
24,145
-25,911
-52% -$957K 0.06% 371
2025
Q2 		$1.78M Buy
50,056
+10,519
+27% +$341K 0.07% 336
2025
Q1 		$1.34M Buy
39,537
+33,096
+514% +$1.19M 0.06% 371
2024
Q4 		$210K Sell
6,441
-4,152
-39% -$172K 0.01% 652
2024
Q3 		$516K Sell
10,593
-136
-1% -$7.24K 0.02% 568
2024
Q2 		$475K Buy
10,729
+2,825
+36% +$130K 0.04% 544
2024
Q1 		$443K Buy
7,904
+1,864
+31% +$112K 0.06% 429
2023
Q4 		$363K Sell
6,040
-948
-14% -$60.1K 0.07% 290
2023
Q3 		$469K Sell
6,988
-880
-11% -$61.1K 0.1% 237
2023
Q2 		$543K Buy
+7,868
New +$514K 0.11% 231

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Harbor Capital Advisors's LEGN Position: Q1 2026 in Review

Harbor Capital Advisors sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 30,141 shares — an estimated $655K sold.

Harbor Capital Advisors first reported a position in LEGN in Q2 2023 and held it in 11 quarters. The position peaked at $1.78M in Q2 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Harbor Capital Advisors reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 30,141 Legend Biotech shares in Q1 2026, an estimated $655K.
  • Harbor Capital Advisors first reported a position in Legend Biotech in Q2 2023 and held it in 11 quarters.
  • Harbor Capital Advisors's Legend Biotech position peaked at $1.78M in Q2 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.